Your browser doesn't support javascript.
loading
Changes in SARS-CoV-2 viral load and titers over time in SARS-CoV-2-infected human corpses.
Nagasawa, Sayaka; Hirata, Yuichiro; Miyamoto, Sho; Ozono, Seiya; Iida, Shun; Katano, Harutaka; Tsuneya, Shigeki; Kira, Kei; Kobayashi, Susumu; Nakajima, Makoto; Abe, Hiroyuki; Ikemura, Masako; Yamamoto, Isao; Nakagawa, Kimiko; Kubota, Kazumi; Akitomi, Shinji; Hasegawa, Iwao; Ushiku, Tetsuo; Suzuki, Tadaki; Iwase, Hirotaro; Makino, Yohsuke; Saitoh, Hisako.
Afiliación
  • Nagasawa S; Department of Legal Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Hirata Y; Department of Legal Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Miyamoto S; Department of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.
  • Ozono S; Department of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.
  • Iida S; Department of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.
  • Katano H; Department of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.
  • Tsuneya S; Department of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.
  • Kira K; Department of Legal Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Kobayashi S; Department of Forensic Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Nakajima M; Department of Forensic Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Abe H; Department of Forensic Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Ikemura M; Department of Forensic Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Yamamoto I; Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Nakagawa K; Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Kubota K; Department of Forensic Medicine, Kanagawa Dental University, Kanagawa, Japan.
  • Akitomi S; Public Interest Incorporated Association Nihon Kousei-Kyoukai, Kanagawa, Japan.
  • Hasegawa I; Department of Forensic Medicine, Kanagawa Dental University, Kanagawa, Japan.
  • Ushiku T; Public Interest Incorporated Association Nihon Kousei-Kyoukai, Kanagawa, Japan.
  • Suzuki T; Department of Healthcare Information Management, The University of Tokyo Hospital, Tokyo, Japan.
  • Iwase H; Japan Medical Association Research Institute, Tokyo, Japan.
  • Makino Y; International Research Institute of Disaster Science, Tohoku University, Miyagi, Japan.
  • Saitoh H; Department of Forensic Medicine, Kanagawa Dental University, Kanagawa, Japan.
PLoS One ; 19(3): e0287068, 2024.
Article en En | MEDLINE | ID: mdl-38536820
ABSTRACT
High viral titers of infectious severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been detected in human corpses long after death. However, little is known about the kinetics of infectious SARS-CoV-2 in corpses. In this case series study, we investigated the postmortem kinetics of infectious SARS-CoV-2 in human corpses by collecting nasopharyngeal swab samples at multiple time points from six SARS-CoV-2-infected patients after their death. SARS-CoV-2 RNA was detected by quantitative reverse transcription-polymerase chain reaction from nasopharyngeal swab samples collected from all six deceased patients. A viral culture showed the presence of infectious virus in one deceased patient up to 12 days after death. Notably, this patient had a shorter time from symptom onset to death than the other patients, and autopsy samples showed pathological findings consistent with viral replication in the upper respiratory tract. Therefore, this patient died during the viral shedding phase, and the amount of infectious virus in the corpse did not decrease over time up to the date of autopsy (12 days after death). The findings of this study indicate that the persistence of SARS-CoV-2 in corpses can vary among individuals and may be associated with the stage of the disease at the time of death. These important results complement many previously reported findings on the infectivity of SARS-CoV-2 at postmortem.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Límite: Humans Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2024 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Límite: Humans Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2024 Tipo del documento: Article País de afiliación: Japón